Silence Therapeutics
Silence Therapeutics is a biotech company that is developing drugs based on RNA interference, a Nobel Prize winning technology that can selectively "silence" genes linked to the onset of disease. Powerscourt works with Silence Therapeutics on its financial PR and in improving the understanding of the company’s science and potential.